article thumbnail

Teva Pharmaceuticals, collaborators team up to donate behavioral health meds to free clinics, pharmacies

Fierce Healthcare

Teva Pharmaceuticals, collaborators team up to donate behavioral health meds to free clinics, pharmacies agliadkovskaya Thu, 05/04/2023 - 14:30

article thumbnail

How Pharmaceuticals Can Unlock the Power of Influencer Marketing

Healthcare Success

But with all the regulations, can pharmaceutical marketers really utilize influencers to reach consumers and HCPs? This episode is essential listening for pharmaceutical and other healthcare leaders looking for modern ways to engage their audience, increase brand awareness, and boost sales. I'm a pharmaceutical physician.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Out-of-pocket spending on prescriptions grew even after accounting for rebates: study

Fierce Healthcare

There's no shortage of attention on rising pharmaceutical costs, but policymakers need to have the full picture of trends in this space to work off of, according to a new study.

article thumbnail

Leveraging Technology to Improve Pharmaceutical Oversight and Patient Safety

HIT Consultant

In a time when healthcare is always changing, the pharmaceutical sector is under more pressure to ensure patient safety while maintaining compliance with stringent regulatory standards. As the complexity of pharmaceutical delivery rises, technology has become ever more crucial in tracking and safeguarding pharmacological products.

article thumbnail

Healthcare costs will grow 7% next year, PwC finds

Health Care Dive

Providers are expected to seek rate increases from payers as they struggle with labor costs, while health plans will face pressure from increased pharmaceutical expenses.

article thumbnail

Large employers forecast 7.8% hike in health costs next year, thanks to rising pharmacy spend

Health Care Dive

The growing burden of pharmaceuticals is expected to be the primary driver of higher healthcare spending in 2025, mostly due to expensive GLP-1 drugs in demand for weight loss, according to the Business Group on Health.

article thumbnail

Why is the market design for innovative pharmaceuticals not well understood?

Healthcare ECONOMIST

A lot of people when they look at pharmaceutical prices think they are ‘too high’ or ‘too low’ But the question is, too high or too low relative to what? What are our goals in pharmaceutical pricing. That is the title of a fantastic editorial from Olivença et al.